Masoprocol - Shaman Pharmaceuticals

Drug Profile

Masoprocol - Shaman Pharmaceuticals

Alternative Names: SP 134101

Latest Information Update: 05 Dec 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Shaman Pharmaceuticals
  • Developer Merck Sante; Shaman Pharmaceuticals
  • Class Anti-inflammatories; Catechols; Lignans; Small molecules
  • Mechanism of Action Lipoxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypertension; Type 2 diabetes mellitus

Most Recent Events

  • 27 Jul 2000 Discontinued-Preclinical for Hypertension in USA (PO)
  • 27 Jul 2000 Discontinued-Preclinical for Type-2 diabetes mellitus in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top